GA201 (RG7160): A Novel, Humanized, Glycoengineered Anti-EGFR Antibody with Enhanced ADCC and Superior In Vivo Efficacy Compared with CetuximabGERDES, Christian A; NICOLINI, Valeria Gonzalez; BOSSENMAIER, Birgit et al.Clinical cancer research (Print). 2013, Vol 19, Num 5, pp 1126-1138, issn 1078-0432, 13 p.Article

Correlation of dendritic cell maturation and the formation of aggregates of poly-ubiquitinated proteins in the cytosolFASSBENDER, Melanie; HERTER, Sylvia; HOLTAPPELS, Rafaela et al.Medical microbiology and immunology. 2008, Vol 197, Num 2, pp 185-189, issn 0300-8584, 5 p.Article

Cytomegalovirus encodes a positive regulator of antigen presentationHOLTAPPELS, Rafaela; GILLERT-MARIEN, Dorothea; THOMAS, Doris et al.Journal of virology. 2006, Vol 80, Num 15, pp 7613-7624, issn 0022-538X, 12 p.Article

Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicityMÖSSNER, Ekkehard; BRÜNKER, Peter; FERRARA, Claudia et al.Blood. 2010, Vol 115, Num 22, pp 4393-4402, issn 0006-4971, 10 p.Article

Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAF^V600E Mutational Status and Sustained Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathway SuppressionHOEFLICH, Klaus P; HERTER, Sylvia; STERN, Howard et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 7, pp 3042-3051, issn 0008-5472, 10 p.Article